InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: Thurly post# 91003

Saturday, 09/08/2012 1:32:52 PM

Saturday, September 08, 2012 1:32:52 PM

Post# of 345981
Thurly, sorry, but I just don't buy this argument. If I was Roche, and I had bavi ,and it had been shown
to have much better survival than anything else, then I would be pushing development of bavi,
not delaying it. With a much better product you can take market share away from your competitors.
There are only so many cancer patients, the only way to grow your share is to take them away from
your competition, sitting on bavi won't do that.
I would favor a deal with Roche because they have Genentech which has the best researchers in the
biotech world. I think the combination of brains and money could move bavi along faster than any other company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News